2 ms·
A GLP-1 drug trial 12 years ago by a major pharma company was stopped because of increased suicide risk (2 in 10,000) among the cohort. We will see what happen
by RachelF 2y ago
A GLP-1 drug trial 12 years ago by a major pharma company was stopped because of increased suicide risk (2 in 10,000) among the cohort.
We will see what happens long term the second time around.
- chpatrick 2y agoIt's not even the second time around now, liraglutide was approved a decade ago.
- phonon 2y ago"Compared with those prescribed lifestyle intervention for obesity, adolescents prescribed either liraglutide (Saxenda; Novo Nordisk) or semaglutide (Wegovy; Novo Nordisk) had a 33% lower risk of suicidality over 12 months of follow-up after controlling for potential baseline confounders."[1] [1]https://www.tctmd.com/news/defying-earlier-glp-1-data-study-teens-sees-possible-mental-health-gains https://www.tctmd.com/news/defying-earlier-glp-1-data-study-...